🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Puppy and ducklings.. 😊

🚨 This is your last chance to register for the 40th edition of the Chemotherapy courses of Gustave Roussy. 🚨 Join us for the 40th anniversary of this annual event and discuss with us the last updates about #cancer treatment: tinyurl.com/5cfyx7t8

Here's our latest, led by Drs. Riaz Gillani & Ryan Collins - we studied a type of inherited genetic event (structural variants) + risk of developing certain cancers in kids: Dana-Farber News Dana-Farber Division of Population Sciences Boston Children's Broad Institute Science Magazine science.org/doi/10.1126/sc…

Don’t miss this one ! 4th “exchanges “ between Dana-Farber & Gustave Roussy —this time around “Radioligand Therapies”, with the help of Servier support and Medscape for logistics--March 25th in beautiful Paris! Free registration: events.medscapelive.org/website/82041/ OncoAlert

⏰ Final hours to benefit from the best rates for #ESMOTAT25 👉 Be part of this multi-stakeholder forum to discover the future of anticancer drugs. Early registration ends on 15 Jan at 23:59 CET. 🔗 Secure your place here: ow.ly/Kw6i50UGJ41

Get the latest in early clinical trials at ESMO TAT 2025, from bispecific antibodies for IO, cell therapies in solid tumours (CART, NK cells, modified TCRs, TIL therapy) to MAPkinase pathway and associated targets (KRAS G12C, MAP2K4, combos). Register now!

La station de métro Villejuif - Gustave Roussy de la Ligne 14 a ouvert ses portes aujourd'hui ! Plus qu'une #station, c'est un lien direct qui rapproche des milliers de personnes des soins, de l'innovation et de la recherche.

ESMO announces Philippe Bedard as the recipient of the 2025 TAT Honorary Award for his outstanding contributions to advancing targeted anticancer therapies. 📅 He will deliver his award lecture on 3 March at the #ESMOTAT25 in Paris 📌 ow.ly/eue550UT7eX

Opening session of #ESMOAFrica2025 by the ESMO - Eur. Oncology president FabriceAndre with the amazing audience from all over Africa. OncoAlert G Curigliano MD PhD Evandro de Azambuja, MD, PhD

📣 ESMO #ClinicalPracticeGuideline eUpdate on #OesophagealCancer: in resectable, locally advanced oesophageal adenocarcinoma or OGJ pre- & post-operative #chemotherapy is associated with improved survival vs #Neoadjuvant #Chemoradiotherapy. 🔗 ow.ly/R37w50UYlE9

📣 Join us for an insightful ESMO Webinar on Advanced Urothelial Cancer! 👩‍⚕️Our expert panel will discuss 1st & 2nd line therapies, toxicity management & more. Live Q&A included. 👉Register now! #UrothelialCancer 🔗ow.ly/Etpg50V07hR

Abstract submission now open for #ESMO25 in #BERLIN! We have a fantastic educational programme in place, and now it's time for the scientific programme. Looking forward to your abstracts! Deadline: May13th esmo.org/meeting-calend… Toni Choueiri, MD ESMO - Eur. Oncology Toni Choueiri, MD FabriceAndre

📢 New publication from Gustave Roussy researchers & collaborators in Nature Cancer further supports the tumor-agnostic indication of pembrolizumab ! 📢 Read the study: doi.org/10.1038/s43018…

👉 Share your findings with regional and international experts in #cancer #drugdevelopment. ⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region Submit now: 🔗 ow.ly/iagq50VuAmn

📣ESMO #ClinicalPracticeGuideline Express Update on #PancreaticCancer: updated 1st- & #2nd-line treatment recommendations for managing #MetastaticPancreaticCancer, following approval of 1st-line nanoliposomal #irinotecan. #ESMOGuidelines 🔗ow.ly/H7Ap50Vx9Qj

It was very sad to learn that M Schneider passed away. Maurice created ESMO - Eur. Oncology in 1975 together with G Mathe, in Ville de Nice 50 years later, ESMO - Eur. Oncology includes almost 45k members around the 🌍, trains all generations of doctors and transforms practice of oncology w its frameworks

📢 #ESMOFellowship applications are now open! The Society is committed to supporting #YoungOncologists in developing high-quality #TranslationalResearch or #ClinicalResearch projects. 📅 Apply by: 29 May 2025 🔗 ow.ly/tz3e50VAQuM Evandro de Azambuja, MD, PhD Teresa Amaral, MD, PhD

#ESMOBreast25 is next month. Love this "digestible" breast only meeting with the benefits of extra interaction with all of our international colleagues. Registration: esmo.org/meeting-calend… Program: cslide.ctimeetingtech.com/coasis_21219/a… #bcsm ESMO - Eur. Oncology G Curigliano MD PhD FabriceAndre

At #ASCO25, the Joint Session between ASCO and ESMO - Eur. Oncology will discuss emerging trends & the implications of integrating biomarker testing into clinical care. #ASCODailyNews has more on this with: Robin Zon, MD, FACP, FASCO Ben Westphalen FabriceAndre Arturo LoAIza-Bonilla, MD MSEd Julie Gralow: brnw.ch/21wSLDe

📣 Join us in Hong Kong for a chance to contribute to oncology drug development in Asia Pacific! ⏰ Late registration deadline: 18 June 🔗 ow.ly/MWyG50W90Ef Herbert Loong, MBBS, FASCO Tony Mok Ben Tran Aya Helali MD PhD